WallStSmart

Core Scientific, Inc. Common Stock (CORZ) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target

Core Scientific, Inc. Common Stock stock (CORZ) is currently trading at $15.81. Core Scientific, Inc. Common Stock PS ratio (Price-to-Sales) is 16.23. Analyst consensus price target for CORZ is $26.40. WallStSmart rates CORZ as Sell.

  • CORZ PE ratio analysis and historical PE chart
  • CORZ PS ratio (Price-to-Sales) history and trend
  • CORZ intrinsic value — DCF, Graham Number, EPV models
  • CORZ stock price prediction 2025 2026 2027 2028 2029 2030
  • CORZ fair value vs current price
  • CORZ insider transactions and insider buying
  • Is CORZ undervalued or overvalued?
  • Core Scientific, Inc. Common Stock financial analysis — revenue, earnings, cash flow
  • CORZ Piotroski F-Score and Altman Z-Score
  • CORZ analyst price target and Smart Rating
CORZ

Core Scientific, Inc.

NASDAQTECHNOLOGY
$15.81
$0.67 (-4.07%)
52W$6.20
$23.63
Target$26.40+67.0%

📊 No data available

Try selecting a different time range

WallStSmart

Smart Analysis

Core Scientific, Inc. Common Stock (CORZ) · 7 metrics scored

Smart Score

25
out of 100
Grade: F
Avoid
Investment Rating

Category Performance

WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.

Investment Thesis

Strong fundamentals in eps growth, institutional own.. Concerns around operating margin and price/sales. Significant fundamental concerns warrant caution or avoidance.

Core Scientific, Inc. Common Stock (CORZ) Key Strengths (3)

Avg Score: 9.0/10
EPS GrowthGrowth
61.20%10/10

Earnings per share surging 61.20% year-over-year

Institutional Own.Quality
117.62%10/10

117.62% of shares held by major funds and institutions

Market CapQuality
$5.18B7/10

Mid-cap company balancing growth potential with stability

Supporting Valuation Data

CORZ Target Price
$26.4
53% Upside

Core Scientific, Inc. Common Stock (CORZ) Areas to Watch (4)

Avg Score: 0.5/10
Operating MarginProfitability
-78.50%0/10

Losing money on operations

Revenue GrowthGrowth
-16.00%0/10

Revenue declining -16.00%, a shrinking business

Profit MarginProfitability
-90.50%0/10

Company is losing money with a negative profit margin

Price/SalesValuation
16.232/10

Very expensive at 16.2x annual revenue

Supporting Valuation Data

Forward P/E
121.95
Expensive
Price/Sales (TTM)
16.23
Overvalued
EV/Revenue
18.9
Premium

Core Scientific, Inc. Common Stock (CORZ) Detailed Analysis Report

Overall Assessment

This company scores 25/100 in our Smart Analysis, earning a F grade. Out of 7 metrics analyzed, 3 register as strengths (avg 9.0/10) while 4 fall into concern territory (avg 0.5/10). The category breakdown reveals uneven performance, with some areas requiring attention.

The Bull Case

The strongest argument centers on EPS Growth, Institutional Own., Market Cap. Growth metrics are encouraging with EPS Growth at 61.20%.

The Bear Case

The primary concerns are Operating Margin, Revenue Growth, Profit Margin. Some valuation metrics including Price/Sales (16.23) suggest expensive pricing. Growth concerns include Revenue Growth at -16.00%, which may limit upside. Profitability pressure is visible in Operating Margin at -78.50%, Profit Margin at -90.50%.

Key Dynamics to Monitor

Three factors to monitor going forward. First, whether Operating Margin improves, as this is the primary drag on the overall score. Second, margin trajectory, with Operating Margin at -78.50% needing improvement to support the investment thesis. Third, growth sustainability, with Revenue Growth at -16.00% needing to reaccelerate.

Risk Considerations

Based on the metric profile, this is a higher risk investment. There are more areas of concern than strength, warranting a more conservative position size. Investors should size positions according to their risk tolerance and maintain diversification.

Bottom Line

Fundamental challenges outweigh strengths at current levels. Operating Margin and Revenue Growth are the primary drags. Consider waiting for meaningful improvement before committing capital.

Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.

Compare CORZ with Competitors

Top SOFTWARE - INFRASTRUCTURE stocks by market cap

Compare any two stocks →

WallStSmart Analysis Synopsis

Data-driven financial summary for Core Scientific, Inc. Common Stock (CORZ) · TECHNOLOGYSOFTWARE - INFRASTRUCTURE

The Big Picture

Core Scientific, Inc. Common Stock is in a turnaround phase, with management focused on restoring profitability. Revenue reached 319M with 16% decline year-over-year. The company is currently unprofitable, posting a -90.5% profit margin.

Key Findings

Low Leverage

Debt-to-equity ratio of -0.94 indicates a conservative balance sheet with 453M in cash.

Revenue Decline

Revenue contracted 16% YoY. Worth determining whether this is cyclical or structural.

Operating at a Loss

The company is unprofitable with a -90.5% profit margin. The path to breakeven will be the key catalyst.

What to Watch Next

Volatility is elevated with a beta of 6.90, so expect amplified moves relative to the broader market.

Sector dynamics: monitor SOFTWARE - INFRASTRUCTURE industry trends, competitive moves, and regulatory changes that could impact Core Scientific, Inc. Common Stock.

Bottom Line

Core Scientific, Inc. Common Stock is in turnaround mode. The path to profitability remains the critical question. Speculative investors may see opportunity in the recovery story, but conservative investors should wait for consistent positive earnings before committing capital.

This synopsis is generated from publicly available financial data. It is not financial advice. Always conduct your own research and consult a qualified financial advisor before making investment decisions.

Insider Transactions(13 last 3 months)

Total Buys
8
Total Sells
5
Mar 9, 2026(1 transaction)
WEISS, ERIC STANTON
Director
Buy
Shares
+7,000
Jan 29, 2026(1 transaction)
SULLIVAN, ADAM TAYLOR
Director, Chief Executive Officer
Sell
Shares
-274,554
Jan 23, 2026(1 transaction)
SULLIVAN, ADAM TAYLOR
Director, Chief Executive Officer
Sell
Shares
-274,404
Dec 30, 2025(1 transaction)
ROZOV, YADIN
Director
Sell
Shares
-40,100

Data sourced from SEC Form 4 filings

Last updated: 11:16:45 PM

About Core Scientific, Inc. Common Stock(CORZ)

Exchange

NASDAQ

Sector

TECHNOLOGY

Industry

SOFTWARE - INFRASTRUCTURE

Country

USA

Core Scientific, Inc. provides blockchain and artificial intelligence (AI) infrastructure services in the United States. The company is headquartered in Austin, Texas.

Visit Core Scientific, Inc. Common Stock (CORZ) Website
838 WALKER ROAD, DOVER, DE, UNITED STATES, 19904